Arch Biopartners(ACHFF)
$0.64-0.02 (-2.58%)
ACHFF
Arch Biopartners financials statements
$0.64
At close:-0.02 (-2.58%)
Arch Biopartners (ACHFF) Income Statement
0 Followers
Arch Biopartners Income Statement
Last quarter (Q3 2026), Arch Biopartners's total revenue was C$0.00. In Q3, Arch Biopartners's net income was C$-475.11K. See Arch Biopartners’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 2.12M | C$ 1.98M | C$ 964.68K | C$ 3.89M | |
| C$ 0.00 | C$ -1.66M | C$ -129.00K | C$ -503.00K | C$ -150.00K | |
| C$ 1.52M | C$ 2.29M | C$ 3.35M | C$ 1.08M | C$ 1.17M | |
| Depreciation and Amortization | C$ 0.00 | C$ 3.46M | C$ 2.90M | C$ 997.10K | C$ 819.38K |
| C$ -1.29M | C$ -75.40K | C$ -335.99K | C$ -101.90K | C$ -76.62K | |
| C$ -1.52M | C$ -3.95M | C$ -3.35M | C$ -1.39M | C$ -1.17M | |
| C$ -35.12K | C$ 26.82K | C$ 28.43K | C$ -18.49K | C$ -4.86K | |
| C$ -1.55M | C$ -3.92M | C$ -3.33M | C$ -1.41M | C$ -1.17M | |
| C$ -1.55M | C$ -3.92M | C$ -3.33M | C$ -1.41M | C$ -1.17M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.02 | C$ -0.06 | C$ -0.05 | C$ -0.02 | C$ -0.02 |
| Diluted EPS | C$ -0.02 | C$ -0.06 | C$ -0.05 | C$ -0.02 | C$ -0.02 |
| Weighted Average Shares Outstanding | 65.60M | 63.38M | 62.47M | 62.16M | 61.32M |
| Weighted Average Shares Outstanding (Diluted) | 65.60M | 63.38M | 62.47M | 62.16M | 61.32M |
Currency in CAD

